The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia

Luciana Teofili, Francesco Pierconti, Annalaura Di Febo, Nicola Maggiano, Nicola Vianelli, Stefano Ascani, Elena Rossi, Stefano Pileri, Giuseppe Leone, Luigi Maria Larocca, Valrio De Stfano

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Using immunohistochemistry, we investigated the expression of c-mpl in bone marrow megakaryocytes of 88 patients with essential thrombocythemia (ET), 6 patients with secondary thrombocytosis (ST), and 20 patients with lymphoma (controls). Considering both the pattern of expression and the staining intensity, we identified a uniform and a heterogeneous pattern of c-mpl expression. The uniform pattern was found in all the controls, all the patients with ST, and 28 of the patients with ET, with a strong staining intensity observed in most megakaryocytes (> 80%). In contrast, c-mpl expression was heterogeneous in 60 patients with ET, 18 of whom (30%) presented with thrombosis at diagnosis, a significant difference from patients with a uniform c-mpl pattern (2 of 28; 7%; P = .026). In particular, the overrepresentation of thrombotic complications in patients with a heterogeneous c-mpl expression pattern was found mainly among patients with a significant percentage (10% to 40%) of weakly stained or c-mpl-negative megakaryocytes (heterogeneous-weak pattern; 13 of 30; 43%; P = .002). Accordingly, this pattern was associated with a 6.1-fold increased risk of thrombosis compared with that of patients with a uniform c-mpl pattern. In conclusion, the presence of a heterogeneous pattern of c-mpl distribution in bone marrow megakaryocytes could be a useful diagnostic criterion in the differential diagnosis of thrombocytosis. Furthermore, detection of a significant percentage of weakly stained or c-mpl-negative megakaryocytes can identify patients with a higher risk of thrombosis.

Original languageEnglish
Pages (from-to)714-717
Number of pages4
JournalBlood
Volume100
Issue number2
DOIs
Publication statusPublished - Jul 15 2002

Fingerprint

Essential Thrombocythemia
Megakaryocytes
Bone
Thrombocytosis
Thrombosis
Bone Marrow
Staining and Labeling
Lymphoma
Differential Diagnosis
Immunohistochemistry

ASJC Scopus subject areas

  • Hematology

Cite this

Teofili, L., Pierconti, F., Di Febo, A., Maggiano, N., Vianelli, N., Ascani, S., ... De Stfano, V. (2002). The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood, 100(2), 714-717. https://doi.org/10.1182/blood.V100.2.714

The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. / Teofili, Luciana; Pierconti, Francesco; Di Febo, Annalaura; Maggiano, Nicola; Vianelli, Nicola; Ascani, Stefano; Rossi, Elena; Pileri, Stefano; Leone, Giuseppe; Larocca, Luigi Maria; De Stfano, Valrio.

In: Blood, Vol. 100, No. 2, 15.07.2002, p. 714-717.

Research output: Contribution to journalArticle

Teofili, L, Pierconti, F, Di Febo, A, Maggiano, N, Vianelli, N, Ascani, S, Rossi, E, Pileri, S, Leone, G, Larocca, LM & De Stfano, V 2002, 'The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia', Blood, vol. 100, no. 2, pp. 714-717. https://doi.org/10.1182/blood.V100.2.714
Teofili L, Pierconti F, Di Febo A, Maggiano N, Vianelli N, Ascani S et al. The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood. 2002 Jul 15;100(2):714-717. https://doi.org/10.1182/blood.V100.2.714
Teofili, Luciana ; Pierconti, Francesco ; Di Febo, Annalaura ; Maggiano, Nicola ; Vianelli, Nicola ; Ascani, Stefano ; Rossi, Elena ; Pileri, Stefano ; Leone, Giuseppe ; Larocca, Luigi Maria ; De Stfano, Valrio. / The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. In: Blood. 2002 ; Vol. 100, No. 2. pp. 714-717.
@article{bc831344439842668c102da4c9d4eda6,
title = "The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia",
abstract = "Using immunohistochemistry, we investigated the expression of c-mpl in bone marrow megakaryocytes of 88 patients with essential thrombocythemia (ET), 6 patients with secondary thrombocytosis (ST), and 20 patients with lymphoma (controls). Considering both the pattern of expression and the staining intensity, we identified a uniform and a heterogeneous pattern of c-mpl expression. The uniform pattern was found in all the controls, all the patients with ST, and 28 of the patients with ET, with a strong staining intensity observed in most megakaryocytes (> 80{\%}). In contrast, c-mpl expression was heterogeneous in 60 patients with ET, 18 of whom (30{\%}) presented with thrombosis at diagnosis, a significant difference from patients with a uniform c-mpl pattern (2 of 28; 7{\%}; P = .026). In particular, the overrepresentation of thrombotic complications in patients with a heterogeneous c-mpl expression pattern was found mainly among patients with a significant percentage (10{\%} to 40{\%}) of weakly stained or c-mpl-negative megakaryocytes (heterogeneous-weak pattern; 13 of 30; 43{\%}; P = .002). Accordingly, this pattern was associated with a 6.1-fold increased risk of thrombosis compared with that of patients with a uniform c-mpl pattern. In conclusion, the presence of a heterogeneous pattern of c-mpl distribution in bone marrow megakaryocytes could be a useful diagnostic criterion in the differential diagnosis of thrombocytosis. Furthermore, detection of a significant percentage of weakly stained or c-mpl-negative megakaryocytes can identify patients with a higher risk of thrombosis.",
author = "Luciana Teofili and Francesco Pierconti and {Di Febo}, Annalaura and Nicola Maggiano and Nicola Vianelli and Stefano Ascani and Elena Rossi and Stefano Pileri and Giuseppe Leone and Larocca, {Luigi Maria} and {De Stfano}, Valrio",
year = "2002",
month = "7",
day = "15",
doi = "10.1182/blood.V100.2.714",
language = "English",
volume = "100",
pages = "714--717",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia

AU - Teofili, Luciana

AU - Pierconti, Francesco

AU - Di Febo, Annalaura

AU - Maggiano, Nicola

AU - Vianelli, Nicola

AU - Ascani, Stefano

AU - Rossi, Elena

AU - Pileri, Stefano

AU - Leone, Giuseppe

AU - Larocca, Luigi Maria

AU - De Stfano, Valrio

PY - 2002/7/15

Y1 - 2002/7/15

N2 - Using immunohistochemistry, we investigated the expression of c-mpl in bone marrow megakaryocytes of 88 patients with essential thrombocythemia (ET), 6 patients with secondary thrombocytosis (ST), and 20 patients with lymphoma (controls). Considering both the pattern of expression and the staining intensity, we identified a uniform and a heterogeneous pattern of c-mpl expression. The uniform pattern was found in all the controls, all the patients with ST, and 28 of the patients with ET, with a strong staining intensity observed in most megakaryocytes (> 80%). In contrast, c-mpl expression was heterogeneous in 60 patients with ET, 18 of whom (30%) presented with thrombosis at diagnosis, a significant difference from patients with a uniform c-mpl pattern (2 of 28; 7%; P = .026). In particular, the overrepresentation of thrombotic complications in patients with a heterogeneous c-mpl expression pattern was found mainly among patients with a significant percentage (10% to 40%) of weakly stained or c-mpl-negative megakaryocytes (heterogeneous-weak pattern; 13 of 30; 43%; P = .002). Accordingly, this pattern was associated with a 6.1-fold increased risk of thrombosis compared with that of patients with a uniform c-mpl pattern. In conclusion, the presence of a heterogeneous pattern of c-mpl distribution in bone marrow megakaryocytes could be a useful diagnostic criterion in the differential diagnosis of thrombocytosis. Furthermore, detection of a significant percentage of weakly stained or c-mpl-negative megakaryocytes can identify patients with a higher risk of thrombosis.

AB - Using immunohistochemistry, we investigated the expression of c-mpl in bone marrow megakaryocytes of 88 patients with essential thrombocythemia (ET), 6 patients with secondary thrombocytosis (ST), and 20 patients with lymphoma (controls). Considering both the pattern of expression and the staining intensity, we identified a uniform and a heterogeneous pattern of c-mpl expression. The uniform pattern was found in all the controls, all the patients with ST, and 28 of the patients with ET, with a strong staining intensity observed in most megakaryocytes (> 80%). In contrast, c-mpl expression was heterogeneous in 60 patients with ET, 18 of whom (30%) presented with thrombosis at diagnosis, a significant difference from patients with a uniform c-mpl pattern (2 of 28; 7%; P = .026). In particular, the overrepresentation of thrombotic complications in patients with a heterogeneous c-mpl expression pattern was found mainly among patients with a significant percentage (10% to 40%) of weakly stained or c-mpl-negative megakaryocytes (heterogeneous-weak pattern; 13 of 30; 43%; P = .002). Accordingly, this pattern was associated with a 6.1-fold increased risk of thrombosis compared with that of patients with a uniform c-mpl pattern. In conclusion, the presence of a heterogeneous pattern of c-mpl distribution in bone marrow megakaryocytes could be a useful diagnostic criterion in the differential diagnosis of thrombocytosis. Furthermore, detection of a significant percentage of weakly stained or c-mpl-negative megakaryocytes can identify patients with a higher risk of thrombosis.

UR - http://www.scopus.com/inward/record.url?scp=0037100542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037100542&partnerID=8YFLogxK

U2 - 10.1182/blood.V100.2.714

DO - 10.1182/blood.V100.2.714

M3 - Article

C2 - 12091373

AN - SCOPUS:0037100542

VL - 100

SP - 714

EP - 717

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -